EMA approval process for anticancer agents: What should the oncologist know?

Date 08 October 2016
Event ESMO 2016 Congress
Session EMA approval process for anticancer agents: What should the oncologist know?
Topics Cytotoxic agents
Bioethics, Legal, and Economic Issues
Therapy
Biological therapy
Presenter Francesco Pignatti
Authors F. Pignatti
  • European Medicines Agency, London/GB